Cite
Influence of ASCT for Multiple Myeloma (MM) on Total Cost of Care Under the CMS Oncology Care Model (OCM)
MLA
Mark Liu, et al. “Influence of ASCT for Multiple Myeloma (MM) on Total Cost of Care Under the CMS Oncology Care Model (OCM).” Biology of Blood and Marrow Transplantation, vol. 24, Mar. 2018, pp. S308–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........35801e820ed626fbbada9737c9c81353&authtype=sso&custid=ns315887.
APA
Mark Liu, Mark Sanderson, & Luis Isola. (2018). Influence of ASCT for Multiple Myeloma (MM) on Total Cost of Care Under the CMS Oncology Care Model (OCM). Biology of Blood and Marrow Transplantation, 24, S308–S309.
Chicago
Mark Liu, Mark Sanderson, and Luis Isola. 2018. “Influence of ASCT for Multiple Myeloma (MM) on Total Cost of Care Under the CMS Oncology Care Model (OCM).” Biology of Blood and Marrow Transplantation 24 (March): S308–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........35801e820ed626fbbada9737c9c81353&authtype=sso&custid=ns315887.